| Literature DB >> 34248640 |
Wuxia Zhang1, Yihua Hu1, Jiaqi He1, Dongdong Guo1, Jinzhong Zhao1, Peng Li1.
Abstract
Lycopi Herba has been broadly used as a traditional medicinal herb in Asia due to its ability to strengthen immunity. However, it is still obscure for its material basis and underlying mechanisms. Polysaccharide, as one of the most important components of most natural herbs, usually contributes to the immunomodulatory ability of herbs. Here, we aimed to detectEntities:
Keywords: Lycopi Herba; NF-κB pathway; immunological activity; polysaccharide; structure
Year: 2021 PMID: 34248640 PMCID: PMC8267152 DOI: 10.3389/fphar.2021.691995
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810
FIGURE 1Extraction and purification scheme of polysaccharide LHPW from Lycopi Herba.
FIGURE 2Monosaccharide composition of mixed monosaccharide standards (A) and LHPW (B).
Methylation analysis of LHPW.
| No. | Rt | Methylated sugar | Mass fragments (m/z) | Molar ratios | Type of linkage |
|---|---|---|---|---|---|
| 1 | 9.375 | 2,3,5-Me3-Araf | 43,71,87,101,117,129,161 | 2.28 | Araf-(1→ |
| 2 | 13.033 | 3,4-Me2-Arap | 43,71,87,99,101,113,117,129,161,189 | 1.53 | →2)-Arap-(1→ |
| 3 | 14.538 | 2,3-Me2-Arap | 43,71,87,101,117,129,161,189 | 1.83 | →4)-Arap-(1→ |
| 4 | 16.228 | 2,3,4,6-Me4-Glcp | 43,71,87,101,117,129,145,161,205 | 5.89 | Glcp-(1→ |
| 5 | 17.451 | 2,3,4,6-Me4-Galp | 43,71,87,101,117,129,145,161,205 | 4.67 | Galp-(1→ |
| 6 | 20.488 | 3,4,6-Me3-Manp | 43,71,87,99,101,129,161,189 | 4.44 | →1)- Fruf--(2→ |
| 7 | 20.828 | 3,4,6-Me3-Glcp | 43,71,87,99,101,129,161,189 | 7.55 | →1)- Fruf--(2→ |
| 8 | 21.07 | 2,3,6-Me3-Galp | 43,87,99,101,113,117,129,131,173,233 | 6.14 | →4)-Galp-(1→ |
| 9 | 21.388 | 2,3,6-Me3-Glcp | 43,87,99,101,113,117,129,131,173,233 | 9.47 | →4)-Glcp-(1→ |
| 10 | 22.213 | 2,4,6-Me3-Galp | 43,87,99,101,117,129,161 | 1.23 | →3)-Galp-(1→ |
| 11 | 22.404 | 2,3,4-Me3-Glpc | 43,87,99,101,117,129,161,189 | 3.01 | →6)-Glcp-(1→ |
| 12 | 22.67 | 2,3,4-Me3-Manp | 43,87,99,101,117,129,161,189 | 1.38 | →6)-Manp-(1→ |
| 13 | 24.407 | 2,3,4-Me3-Galp | 43,87,99,101,117,129,161,189 | 39.56 | →6)-Galp-(1→ |
| 14 | 29.558 | 2,4-Me2-Galp | 43,87,101,117,129,159,189,233 | 10.02 | →3,6)-Galp-(1→ |
1H NMR and13C NMR spectral assignments for LHPW.
| Residues | Glycosyl residues | H1a,b | H2 | H3 | H4 | H5 | H6a.b | |
|---|---|---|---|---|---|---|---|---|
| C1 | C2 | C3 | C4 | C5 | C6 | |||
|
| →6)-α-D-Galp-(1→ | 4.88 | 3.76 | 3.84 | 4.07 | 3.98 | 3.79 | 3.57 |
| 99.10 | 69.71 | 70.73 | 70.08 | 70.66 | 67.78 | |||
|
| →4)-α-D-Glcp-(1→ | 5.29 | 3.53 | 3.86 | 3.54 | 3.75 | 3.78 | ns |
| 101.14 | 72.88 | 74.58 | 78.35 | 72.53 | 61.95 | |||
|
| →3,6)-β-D-Galp-(1→ | 4.44 | 3.54 | 3.65 | 4.07 | 3.84 | 3.93 | 3.83 |
| 104.69 | 71.31 | 81.5 | 69.82 | 74.81 | 70.76 | |||
|
| →1)-β-D-Fruf-(2→ | 3.80,3.60 | ns | 4.15 | 3.99 | 3.75 | 3.65 | 3.73 |
| 62.13 | 105.17 | 78.3 | 75.63 | 82.41 | 63.47 | |||
|
| α-D-Glcp-(1→ | 5.32 | 3.44 | 3.65 | 3.36 | 3.75 | 3.71 | 3.61 |
| 93.76 | 72.59 | 73.98 | 70.59 | 75.74 | 61.67 | |||
|
| →4)-β-D-Galp-(1→ | 4.41 | 3.45 | 3.57 | 3.96 | 3.44 | 3.56 | |
| 104.47 | 73.21 | 73.97 | 79.03 | 74.36 | 62.74 | |||
|
| α-D-Galp-(1→ | 4.88 | 3.74 | 3.84 | 3.96 | 4.07 | 3.79 | 3.57 |
| 99.1 | 69.7 | 70.7 | 72.52 | 70.08 | 62.78 | |||
|
| α-L-Araf-(1→ | 5.14 | 4.1 | 3.84 | 4.03 | 3.73 | 3.61 | |
| 110.62 | 82.62 | 77.97 | 85.22 | 62.64 |
Note: A-H represent the Glycosyl residues in the corresponding rows.
FIGURE 31D NMR spectra of LHPW: (A) 1H NMR, (B) 13C HMR, and (C) DEPT 135. Same as Table 2, A–H represent the Glycosyl residues →6)-α-D-Galp-(1→, →4)-α-D-Glcp-(1→, →3,6)-β-D-Galp-(1→, →1)-β-D-Fruf-(2→, α-D-Glcp-(1→, →4)-β-D-Galp-(1→, α-D-Galp-(1→, α-L-Araf-(1→. The number 1–6 represent the location of hydrogen or carbon in the Glycosyl residues.
FIGURE 4Effects of LHPW on the phagocytosis index, TNF-α production of RAW 264.7 cells. After RAW 264.7 cells were treated with various concentrations of LHPW (50, 100, and 200 μg/ml), the cell cytotoxicity (A), neutral red phagocytosis index (B), and TNF-α production (C) were tested. Data shown were mean ± SD of three independent experiments. (∗∗∗) p < 0.001, (∗∗) p < 0.01, and (∗) p < 0.05 compared with the control. (D) RAW 264.7 cells were pretreated with PBS (No inhibitors) or BAY 11-7082 (3 µM) for 1 h before incubation with 200 μg/ml LHPW or 2 μg/ml LPS for 24 h.
FIGURE 5LHPW activates the NF-κB p65 protein in RAW 264.7 cells. After being treated with 200 μg/ml LHPW or 2 μg/ml LPS for 3 h, NF-κB p65 protein translocated into nuclei (DAPI) was obtained by laser confocal microscopy. The scale bar was placed at the bottom right, and all images have the same scales.
FIGURE 6Effects of LHPW on splenocyte proliferation. The mice spleen cells were incubated with LHPW at different concentrations (50, 100, and 200 μg/ml) alone (A), in the presence of mitogens Con A (5 μg/ml) (B) or LPS (2 μg/ml) (C) for 48 h. MTT was added and incubated. The optical density was then measured at 570 nm. Data were shown as mean ± SD of three independent experiments. (∗∗∗) p < 0.001, (∗∗) p < 0.01, and (∗) p < 0.05 compared with the control group (A), ConA group (B), or LPS group (C).